Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 54 min ago
Peer-reviewedCC BY-NC 4.0Ewha Medical Journal

Irritant contact dermatitis: beyond a diagnosis of exclusion

  1. 1Department of Dermatology, Ewha Womans University College of Medicine, Seoul, Korea

Abstract

Irritant contact dermatitis (ICD) is the most common form of contact dermatitis and a leading cause of occupational skin disease, but remains underrecognized relative to allergic contact dermatitis (ACD). Direct chemical or physical injury to the epidermal barrier causes ICD, which can develop in anyone when exposure intensity or duration exceeds the skin’s repair capacity. ICD is increasingly understood to involve more than barrier disruption: it is an innate immune-mediated inflammatory disorder involving keratinocyte-derived cytokines, neutrophil recruitment, C-C motif chemokine ligand 2–C-C motif chemokine receptor 2–interleukin-1β signaling, Toll-like receptor 3, and inflammasome activation. Host factors, particularly atopic dermatitis and filaggrin loss-of-function variants, further influence susceptibility. Clinical phenotypes range from acute irritant reactions to chronic cumulative dermatitis, and occupational wet work is a major preventable exposure. Distinguishing ICD from ACD is difficult because their clinical and histopathological features overlap, they may coexist, and ICD-related barrier damage may facilitate subsequent allergic sensitization. Diagnosis therefore requires assessment of exposure history, lesion distribution, symptom quality, and temporal course, with patch testing when ACD is suspected. Molecular biomarker panels and noninvasive imaging or barrier-assessment techniques may improve diagnostic precision, but remain investigational. Management should prioritize identifying and removing irritants, reducing exposure, implementing appropriate protective measures, and restoring the epidermal barrier. Recognizing ICD as a distinct clinical entity, rather than simply a diagnosis of exclusion, is essential for accurate diagnosis and effective management of contact dermatitis in clinical practice.

Related

  1. Allergic Contact Dermatitis in Children Over a 20‐Year Period: A Danish Single‐Centre Study
    Laura Krogh Herlin, Anne Bregnhøj, Mette Sommerlund
    Contact DermatitisPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  2. The Diagnosis of Diabetic Striatopathy Requires Typical MRI Features and the Exclusion of All Potential Differential Diagnoses
    Sounira Mehri, Josef Finsterer
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismJ-STAGE
  3. European Society of Contact Dermatitis Guideline for Diagnostic Patch Testing—Recommendations on Best Practice (Update 2026)
    Wolfgang J. C. Uter, Olivier Aerts, Tove Agner +21
    Contact DermatitisPeer-reviewedCC BY17 citedGeneral medicineOpenAlex
  4. Occupational Allergic Contact Dermatitis due to Rubber Additives in Tunisia: A 27‐Year Retrospective Study of Clinical and Occupational Characteristics
    Emna Baraketi, Jihen Hsinet, Nihel Khouja +1
    Contact DermatitisPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  5. Reply to the Comment on "The diagnosis of Diabetic Striatopathy Requires Typical MRI Features and the Exclusion of all Differential Diagnoses"
    Yuya Ando, Masato Kadoya, Ayano Matsunaga +2
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismJ-STAGE
BibTeX
@article{kim2026irritant,
  title = {{Irritant contact dermatitis: beyond a diagnosis of exclusion}},
  author = {Da Yeon Kim and Jin Ju Lee and Hae Young Choi},
  journal = {Ewha Medical Journal},
  year = {2026},
  month = oct,
  doi = {10.12771/emj.2026.01522},
  url = {https://doi.org/10.12771/emj.2026.01522},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Irritant contact dermatitis: beyond a diagnosis of exclusion
AU  - Da Yeon Kim
AU  - Jin Ju Lee
AU  - Hae Young Choi
PY  - 2026
DA  - 2026/10/02
JO  - Ewha Medical Journal
DO  - 10.12771/emj.2026.01522
UR  - https://doi.org/10.12771/emj.2026.01522
AB  - Irritant contact dermatitis (ICD) is the most common form of contact dermatitis and a leading cause of occupational skin disease, but remains underrecognized relative to allergic contact dermatitis (ACD). Direct chemical or physical injury to the epidermal barrier causes ICD, which can develop in anyone when exposure intensity or duration exceeds the skin’s repair capacity. ICD is increasingly understood to involve more than barrier disruption: it is an innate immune-mediated inflammatory disorder involving keratinocyte-derived cytokines, neutrophil recruitment, C-C motif chemokine ligand 2–C-C motif chemokine receptor 2–interleukin-1β signaling, Toll-like receptor 3, and inflammasome activation. Host factors, particularly atopic dermatitis and filaggrin loss-of-function variants, further influence susceptibility. Clinical phenotypes range from acute irritant reactions to chronic cumulative dermatitis, and occupational wet work is a major preventable exposure. Distinguishing ICD from ACD is difficult because their clinical and histopathological features overlap, they may coexist, and ICD-related barrier damage may facilitate subsequent allergic sensitization. Diagnosis therefore requires assessment of exposure history, lesion distribution, symptom quality, and temporal course, with patch testing when ACD is suspected. Molecular biomarker panels and noninvasive imaging or barrier-assessment techniques may improve diagnostic precision, but remain investigational. Management should prioritize identifying and removing irritants, reducing exposure, implementing appropriate protective measures, and restoring the epidermal barrier. Recognizing ICD as a distinct clinical entity, rather than simply a diagnosis of exclusion, is essential for accurate diagnosis and effective management of contact dermatitis in clinical practice.
SN  - 2234-3180
SN  - 2234-2591
ER  -